Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,115.70 --0%
EPS Growth %: +40.3%
Financial Fact:
Revenue: 5.19B
Today's EPS Names:
OCCI, VIVO, PMCB, More
EPS Growth %: +40.3%
Financial Fact:
Revenue: 5.19B
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
(Updated - July 8, 2026 4:37 PM EDT)
Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
- Eli Lilly: Q2 2026 acquired IPR&D charges estimated at $2.80B pre-tax.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Addus HomeCare (ADUS) to Neutral
- CoreWeave (CRWV) call put ratio 1.1 calls to 1 put into share price lower before the bell
- Dell Technologies (DELL) call put ratio 1 call to 1 put into share price lower before the bell
Create E-mail Alert Related Categories
Guidance, Trader TalkRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
